Hallura is building a new technology platform for the creation of the next generation of dermal fillers for aesthetic medicine.
Designed to overcome the limitations of current products, Halluras HA Dermal Fillers are answering the growing demand for soft, natural, noninvasive aesthetic treatments. The companys products are based on its proprietary cross-linking technology, which uses a novel cross-linking mechanism to maintain and protect natural HA long chains.
Hallura has completed a full set of in vivo animal studies of its products, demonstrating excellent safety and a higher potential for skin lifting compared with other leading products currently on the market.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Hallura Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Nov 10, 2022
www.prnewswire.com
"Click Chemistry" Concept Inspires BiOLinkMatrix by HALLURA™: the Next Generation of HA Dermal Fillers
#Partners
Mar 2, 2022
www.prnewswire.com
Hallura Announces Successful Topline Results of European Multi-Site Clinical Trial with its New BiOLinkMatrix HA Aesthetic Dermal Fillers
#Customers
Jul 1, 2020
www.prnewswire.com
Hallura Announces the Appointment of Paul Navarre to Its Board of Directors